Calretinin Immunohistochemistry at Lahore PCR Lab

Calretinin Immunohistochemistry at Lahore PCR Lab

Calretinin Immunohistochemistry (IHC) is a highly specialized, state-of-the-art diagnostic pathology test performed at Lahore PCR Lab in Lahore, Pakistan. Calretinin is a 29-kDa calcium-binding protein belonging to the EF-hand family. Under physiological conditions, it plays a vital role in intracellular calcium buffering, cell cycle regulation, and phototransduction. In clinical pathology, calretinin serves as an invaluable diagnostic biomarker. Its expression is highly specific to certain cell lineages, making Calretinin IHC an essential tool for differentiating complex neoplasms and diagnosing specific congenital disorders.

The test works by utilizing highly specific monoclonal or polyclonal antibodies designed to bind to the calretinin protein within a tissue sample. Once these antibodies bind to their target, a secondary detection system coupled with a chromogen (typically diaminobenzidine, or DAB) is applied. This reaction produces a visible brown precipitate at the site of antigen expression, which is then visualized under a light microscope by a consultant pathologist. The staining pattern of calretinin is characteristically both cytoplasmic and nuclear, which is a critical diagnostic feature when evaluating tissue specimens.

At Lahore PCR Lab, Calretinin IHC is performed using advanced automated staining platforms that ensure optimal antigen retrieval, precise antibody incubation, and highly reproducible results. This technology minimizes manual errors and background staining, providing pathologists with clear, high-contrast slides for accurate interpretation. The anatomical structures evaluated depend on the clinical indication and the site of the biopsy, commonly involving the pleura, peritoneum, gastrointestinal tract, adrenal glands, and central nervous system. The primary diagnostic value of this test lies in its exceptional sensitivity and specificity, particularly in distinguishing malignant mesothelioma from metastatic adenocarcinomas and in confirming the diagnosis of Hirschsprung’s disease in pediatric patients.

Clinical Procedure: What to Expect

Patient Preparation

Because Calretinin Immunohistochemistry is a laboratory test performed on tissue specimens (biopsies or surgical resections), there is no direct physical preparation required for the IHC staining process itself. However, patients must follow specific preparation guidelines for the primary procedure used to obtain the tissue sample:

• Surgical or Core Needle Biopsy: If the tissue is being obtained via an invasive procedure (such as a pleural biopsy, core needle biopsy of a mass, or surgical resection), patients may need to fast for 6 to 8 hours prior to the procedure, especially if local or general anesthesia is administered.
• Medication Management: Patients must consult their referring physician regarding the temporary cessation of blood thinners, antiplatelet medications, or non-steroidal anti-inflammatory drugs (NSAIDs) to minimize the risk of bleeding during the biopsy.
• Pediatric Rectal Biopsy: For infants undergoing a rectal suction biopsy to evaluate for Hirschsprung’s disease, specific bowel preparation or fasting guidelines will be provided by the pediatric surgeon.
• Submission of Existing Blocks: If the biopsy has already been performed at another facility, patients can submit the Formalin-Fixed Paraffin-Embedded (FFPE) tissue block along with the original histopathology report to Lahore PCR Lab for Calretinin IHC analysis.

During the Procedure

The laboratory phase of Calretinin Immunohistochemistry at Lahore PCR Lab follows a rigorous, multi-step scientific protocol to ensure diagnostic accuracy:

• Specimen Reception and Accessioning: The submitted tissue block or freshly cut slides are received, verified against the patient’s clinical history, and assigned a unique laboratory identification number.
• Tissue Sectioning: Ultra-thin sections (typically 3 to 4 micrometers thick) are cut from the paraffin block using a high-precision microtome and mounted onto positively charged glass slides to prevent tissue detachment during processing.
• Deparaffinization and Rehydration: The slides are heated and treated with graded xylene and alcohol solutions to remove the paraffin wax and rehydrate the tissue sections.
• Antigen Retrieval: To expose the calretinin epitopes masked during formalin fixation, the slides undergo Heat-Induced Epitope Retrieval (HIER) using specialized buffer solutions (such as citrate or EDTA) under controlled temperature and pressure.
• Antibody Incubation: The tissue is incubated with a highly specific primary anti-calretinin antibody, followed by a secondary antibody conjugated with horseradish peroxidase (HRP) or alkaline phosphatase (AP).
• Chromogen Visualization: A chromogenic substrate (DAB) is applied, reacting with the enzyme complex to produce a distinct brown staining pattern in cells expressing calretinin.
• Counterstaining and Mounting: The slides are counterstained with hematoxylin to visualize cell nuclei, dehydrated, cleared, and sealed with a coverslip for microscopic evaluation.

When is a Calretinin Immunohistochemistry Performed?

Differentiating Malignant Mesothelioma from Adenocarcinoma

One of the most common and critical indications for Calretinin IHC is the evaluation of pleural or peritoneal masses. Malignant mesothelioma, a highly aggressive tumor associated with asbestos exposure, can clinically and radiologically mimic metastatic adenocarcinoma of the lung or other organs. Because the therapeutic strategies and prognoses for these two malignancies differ drastically, an accurate diagnosis is paramount. Calretinin is highly expressed in normal and neoplastic mesothelial cells, showing diffuse, strong cytoplasmic and nuclear staining in epithelioid mesotheliomas, whereas it is typically negative or only focally positive in adenocarcinomas.

Evaluating Hirschsprung’s Disease in Pediatric Patients

In pediatric pathology, Calretinin IHC is widely recognized as a diagnostic gold standard for Hirschsprung’s disease. This congenital disorder is characterized by the absence of ganglion cells in the distal bowel wall, leading to functional intestinal obstruction. Traditionally, diagnosis relied on identifying ganglion cells on hematoxylin and eosin (H&E) stained sections or utilizing acetylcholinesterase (AChE) histochemistry on frozen sections. Calretinin IHC provides a highly reliable alternative; in a normal bowel, calretinin-positive nerve fibers are clearly visible in the lamina propria and muscularis mucosae. In Hirschsprung’s disease, these calretinin-positive mucosal nerve fibers are entirely absent, allowing for a definitive and objective diagnosis.

Characterizing Adrenocortical Tumors

Calretinin is highly expressed in the normal adrenal cortex and tumors derived from it. Pathologists frequently utilize Calretinin IHC to differentiate adrenocortical carcinomas from other malignancies that may metastasize to the adrenal gland, such as renal cell carcinoma or hepatocellular carcinoma. A strong, diffuse positive stain for calretinin strongly supports an adrenocortical origin, helping oncologists formulate appropriate, targeted treatment plans for patients presenting with adrenal masses.

Investigating Central Nervous System Neoplasms

Within the central nervous system, calretinin is expressed in specific subpopulations of neurons, particularly in the cerebral cortex and cerebellum. In neuro-oncology, Calretinin IHC is employed to characterize various brain tumors. It helps identify neuronal differentiation in neoplasms such as gangliogliomas, central neurocytomas, and certain types of medulloblastomas. It is also useful in distinguishing specific subtypes of ependymomas and other glial tumors, contributing to precise tumor grading and classification.

Assisting in Complex Oncological Workups

For patients presenting with metastatic cancer of unknown primary origin (CUP), Calretinin IHC is often included in a comprehensive immunohistochemical panel. When a patient presents with malignant ascites or pleural effusion, evaluating the cytological preparation or cell block with calretinin helps determine whether the atypical cells are reactive mesothelial cells, malignant mesothelioma, or metastatic carcinoma cells, thereby guiding the search for the primary tumor site.

What Does a Calretinin Immunohistochemistry Detect?

Calretinin Immunohistochemistry detects the presence, localization, intensity, and distribution of the calretinin protein within tissue sections. Specifically, it identifies:

• Diffuse Nuclear and Cytoplasmic Staining: The classic positive staining pattern characteristic of epithelioid malignant mesothelioma.
• Absence of Staining in Epithelial Malignancies: Helps rule out lung, breast, colon, and prostate adenocarcinomas.
• Presence of Mucosal Nerve Fibers: Normal calretinin-positive nerve fibers in the lamina propria of rectal biopsies, ruling out Hirschsprung’s disease.
• Absence of Mucosal Nerve Fibers: Confirms the diagnosis of aganglionosis (Hirschsprung’s disease) in pediatric rectal suction biopsies.
• Adrenocortical Differentiation: Strong positivity in adrenocortical adenomas and carcinomas.
• Normal Mesothelial Cells: Positive staining in benign, reactive mesothelial cells in pleural or peritoneal fluid.
• Leydig and Sertoli Cell Expression: Positivity in specific sex cord-stromal tumors of the testes.
• Ovarian Theca and Granulosa Cells: Expression in specific ovarian stromal tumors.
• Neuronal Subpopulations: Identifies specific calretinin-expressing interneurons in the central nervous system.
• Ganglion Cell Positivity: Confirms the presence of mature ganglion cells in the submucosal and myenteric plexuses.
• Adenomatoid Tumors: Strong positivity in benign adenomatoid tumors of the genital tract.
• Ameloblastomas: Variable expression in specific odontogenic tumors.
• Cardiac Myxomas: Positive staining in the stromal cells of these benign cardiac tumors.
• Synovial Sarcoma: Focal or patchy positivity in a subset of synovial sarcomas.
• Mesothelioma of the Tunica Vaginalis: Confirms mesothelial origin in testicular adnexal masses.
• Deciduoid Mesothelioma: Helps differentiate this rare variant of mesothelioma from deciduoid squamous cell carcinoma.
• Reactive vs. Neoplastic Mesothelium: Assists in evaluating the nature of mesothelial proliferations.
• Clear Cell Renal Cell Carcinoma Negativity: Helps distinguish renal tumors from adrenocortical tumors.
• Hepatocellular Carcinoma Negativity: Aids in the differential diagnosis of upper abdominal masses.
• Mast Cell Positivity: Identifies mast cells, which can sometimes act as an internal control or a diagnostic pitfall.
• Staining Intensity: Categorizes expression as weak, moderate, or strong to assist in semi-quantitative analysis.
• Staining Proportion: Determines the percentage of tumor cells expressing the marker (focal vs. diffuse).

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely diagnostic results are critical for clinical decision-making, particularly in oncology and pediatric emergencies. The turnaround time for Calretinin Immunohistochemistry is typically 3 to 5 working days. This duration is necessary to ensure the highest standards of quality control, including precise tissue processing, antigen retrieval, automated staining, and a comprehensive double-review process by our consultant histopathologists.

Once the report is finalized, patients and referring physicians are immediately notified via SMS. Reports can be accessed and downloaded securely through the Lahore PCR Lab online portal. Physical copies of the reports, complete with high-resolution microscopic images of the IHC stains if requested, can also be collected directly from our main diagnostic center in Lahore.

Calretinin Immunohistochemistry Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Pleural Tissue (Mesothelium vs. Lung)	Strong, diffuse cytoplasmic and nuclear staining in normal mesothelial cells. Negative in lung parenchyma.	Strong, diffuse staining in malignant mesothelioma; negative or focal weak staining in lung adenocarcinoma.
Rectal Mucosa (Pediatric Biopsy)	Abundant calretinin-positive nerve fibers in the lamina propria and muscularis mucosae.	Complete absence of calretinin-positive nerve fibers, indicating Hirschsprung’s disease.
Adrenal Gland Tissue	Diffuse positivity in the cells of the adrenal cortex.	Strong positivity in adrenocortical carcinoma; negative in metastatic renal cell carcinoma.
Brain and Spinal Cord Tissue	Positive staining in specific cortical interneurons and cerebellar Purkinje cells.	Variable positivity in gangliogliomas, neurocytomas, and specific neuronal tumors.
Peritoneal Washings / Fluid	Positive staining in benign, reactive mesothelial cells.	Diffuse, intense staining in metastatic mesothelioma cells; negative in metastatic ovarian serous carcinoma.
Testicular / Ovarian Stromal Tissue	Positivity in Leydig, Sertoli, and ovarian stromal cells.	Strong positivity in sex cord-stromal tumors; negative in germ cell tumors.
Soft Tissue Masses	Typically negative in most soft tissue structures.	Focal or patchy positivity in synovial sarcomas or epithelioid sarcomas.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Calretinin Immunohistochemistry?

• Experienced Healthcare Professionals: Our histopathology department is led by highly qualified consultant pathologists with extensive experience in oncological pathology and immunohistochemistry.
• Patient-Focused Care: We prioritize patient comfort and clarity, providing detailed guidance throughout the testing process.
• Quality Diagnostic Services: Lahore PCR Lab adheres to strict international quality control standards, ensuring highly reliable and reproducible IHC results.
• Professional Reporting: Our reports are comprehensive, featuring detailed microscopic descriptions, staining intensity grades, and clinical correlations.
• Modern Diagnostic Approach: We utilize advanced automated IHC staining platforms that minimize background staining and maximize diagnostic specificity.
• Comfortable Environment: Our main facility in Lahore offers a professional, clean, and welcoming environment for patients submitting samples or undergoing biopsies.
• Convenient Location: Located centrally in Lahore, our laboratory is easily accessible to patients from all parts of the city and surrounding regions.
• Commitment to Accurate Diagnosis: We understand the critical impact of our reports on cancer treatment planning and pediatric surgeries, maintaining an unwavering commitment to diagnostic precision.